Continuous prediction of glucose levels and hypoglycemia events is critical for managing type 1 diabetes mellitus (T1DM) under intensive insulin therapy. Existing models focus on a single task, limiting their practicality and adaptability in…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, an insulin delivery and diabetes technology company, has announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use…
Continue Reading
Background: Carbohydrate counting (CC) is vital for individuals living with type 1 diabetes mellitus (T1DM), yet formal training is often lacking in many contexts. To bridge this gap, the parents of a person living…
Continue Reading
Mums-to be in England with type 1 diabetes will receive a pregnancy-specific ‘artificial pancreas’ from the NHS so they can effectively manage their blood glucose levels.
Around 2,000 women with type 1 diabetes become pregnant…
Welcome to the July edition of Digital Health Digest!This month, we bring you the latest in healthcare innovation—from regulatory updates and groundbreaking partnerships to major funding milestones and inclusive health products. Stay tuned as…
Continue Reading
Generative AI Helps Kids Manage Their Diabetes
Diabetes can lead to complications such as amputations, blindness and heart attacks if blood sugar is not managed properly. For young children with type 1 diabetes, a lifelong…
What You Should Know:
– Sequel Med Tech, a company developing state-of-the-art insulin delivery technologies, announced a commercial development agreement with Abbott.
– The collaboration aims for the future integration of Sequel’s twiist™ Automated Insulin Delivery…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, a leader in insulin delivery and diabetes technology announced the U.S. commercial launch of Control-IQ+ technology.
– This update provides users with greater flexibility and control over their…
Continue Reading
What You Should Know:
– Sequel Med Tech, LLC, a company focused on developing cutting-edge insulin delivery technologies, has announced that its innovative twiist™ Automated Insulin Delivery (AID) System, powered by Tidepool, will be the…
Continue Reading
What You Should Know:
– The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded…
Continue Reading
